Intuity Medical, Inc.

Key People

• George Zamanakos - President and Chief Executive Officer
• Robert Lopez - Vice President, Finance and Corporate Controller
• Margie Amirkiai - Senior Director, Human Resources
• Rashelle Mason - Vice President, Sales, Trade and Market Access
• Dave Yamauchi - Vice President, Marketing
• Mike Wallace - Vice President, Operations
• Raul Escutia - Vice President, Research and Development
• Farhan Shahab - Senior Director, Quality and Regulatory
• Beckie Robertson - Director
• Daniel Einhorn - Scientific Advisory Board Member
• John E. Anderson - Scientific Advisory Board Member

Assessment

Team

Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical technology and business management.

The executive team includes individuals with significant experience in the medical device industry, suggesting a strong foundation for the company's strategic direction and operational execution.

Clinical Need

Aspect: Very Strong
Summary: The POGO Automatic Blood Glucose Monitoring System addresses a significant need for simplified diabetes management.

By integrating lancing, blood collection, and analysis into a single device, the POGO system offers a convenient solution for individuals managing diabetes, potentially improving adherence and outcomes.

Competition

Aspect: Somewhat crowded
Summary: The glucose monitoring market is competitive, with several established players.

While the POGO system offers unique features, it competes in a market with numerous alternatives, requiring effective differentiation and marketing strategies.

Technical Challenge

Aspect: Predictable
Summary: The technology integrates existing components in an innovative way.

Combining lancing, blood collection, and analysis into a single device involves known technologies, reducing the likelihood of unforeseen technical challenges.

Patent

Aspect: Strong
Summary: The company holds patents protecting its integrated glucose monitoring system.

Strong patent protection can deter competitors and support the company's market position, enhancing its valuation and attractiveness to investors.

Financing

Aspect: Well-funded
Summary: The company has secured substantial funding over multiple rounds.

With over $300 million raised, the company has the financial resources to advance its product and expand market reach, though it must manage capital efficiently to achieve profitability.

Regulatory

Aspect: 510k/PMA
Summary: The POGO system has received FDA clearance.

FDA clearance indicates the product meets safety and efficacy standards, enabling the company to market the device in the U.S. and pursue additional regulatory approvals globally.

Opportunity Rollup

Odds of Success

3.7

Peak Market Share

4.7

Segment CAGR

9.5%

Market Segment

Glucose Monitoring

Market Sub Segment

Blood Glucose Meters

Key Takeaway

Intuity Medical's POGO system addresses a significant need in diabetes management with its innovative design, supported by a strong team and substantial funding, though it faces challenges in a competitive market.